Evidence map›Paper›PMID 26594611›Full record

ArticleCurrent clinical microbiology reports2015

Human Babesiosis: Pathogens, Prevalence, Diagnosis and Treatment.

Rosalynn Louise Ord, Cheryl A Lobo

Open access · bronzeAbstract read
In one paragraph

Article in Current clinical microbiology reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed, 1 pooled it
4.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 1 synthesis or guideline pooled it, 114 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Babesiosis and Its Significance in Transfusion Medicine from a European Point of View.Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Human babesiosis: The past, present and future.Expert reviews in molecular medicine · 2025
    Review
  10. Article
  11. Review
  12. Application of Multiplatform Mass Spectrometry to the Study ofInternational journal of molecular sciences · 2025
    Article
  13. Distribution ofParasite epidemiology and control · 2025
    Review
  14. Article
  15. Article
  16. ContinuousInfection and immunity · 2024
    Article
  17. Article
  18. Article
  19. Tick-Borne Diseases of Humans and Animals in West Africa.Pathogens (Basel, Switzerland) · 2023
    Review
  20. Article

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Rosalynn Louise OrdDepartment of Blood-Borne Parasites, Lindsley Kimball Research Institute, New York Blood Center, New York, NY, 10065, USA.
Cheryl A LoboDepartment of Blood-Borne Parasites, Lindsley Kimball Research Institute, New York Blood Center, New York, NY, 10065, USA.
New York Blood Center · US

Funding

Babesiosis: An Emerging Infectious Threat to Transfusion MedicineR01HL105694 · NHLBI · NEW YORK BLOOD CENTER · PI LOBO, CHERYL ANN · 2011 to 2015
$2.0M
Continuous in vitro culture of Babesia microtiR21HL129215 · NHLBI · NEW YORK BLOOD CENTER · PI LOBO, CHERYL ANN · 2015 to 2016
$471k
NHLBI NIH HHS R01 HL105694NHLBI NIH HHS R21 HL129215
6 · The paper itself

Abstract

Human babesiosis is a zoonotic disease caused by protozoan parasites of the

Indexed as

BabesiaB. divergensB. microtimalariaTransfusion-transmitted babesiosiszoonosis

Identifiers

PMID26594611
PMCPMC4649939
OpenAlexW1800976651

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.